Equine sarcoids - Part 3: Association with bovine papillomavirus

Vlaams Diergeneeskundig Tijdschrift

Volumn 77, Issue 3, 2008, Pages 131-137

  Bogaert, Lies ^a   Martens, A ^a   Depoorter, Pieter ^a   Gasthuys, F ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BOS; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; EQUIDAE; PAPILLOMAVIRIDAE;

EID: 52249097465     PISSN: 03039021     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Amtmann E., Muller H., Sauer G. (1980). Equine Connective-Tissue Tumors Contain Unintegrated Bovine Papilloma-Virus DNA. Journal of Virology 35, 962-964.
2. Angelos J.A., Marti E., Lazary S., Carmichael L.E. (1991). Characterization of BPV-like DNA in equine sarcoids. Archives of Virology 119, 95-109.
3. Ashby A.D.M., Meagher L., Campo M.S., Finbow M.E. (2001). E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H+-ATPase. Journal of General Virology 82, 2353-2362.
4. Ashrafi G.H., Tsirimonaki E., Marchetti B., O'Brien P.M., Sibbet G.J., Andrew L., Campo M.S. (2002). Downregulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248-259.
5. Barthold S.W., Olson C. (1978). Common Membrane Neo-Antigens on Bovine Papilloma Virus-Induced Fibroma Cells from Cattle and Horses. American Journal of Veterinary Research 39, 1643-1645.
6. Blair E., Darby G., Gough G., Littler E., Rowlands D., Tisdale M. (1998). Chemotherapy of human papillomavirus infections. In: Antiviral Therapy. BIOS Scientific Publishers Limited, Springer-Verlag, New York, p. 121-125.
7. Bloch N., Breen M., Spradbrow P.B. (1994a). Genomic Sequences of Bovine Papillomaviruses in Formalin-Fixed Sarcoids from Australian Horses Revealed by Polymerase Chain-Reaction. Veterinary Microbiology 41, 163-172.
8. Bloch N., Sutton R.H., Spradbrow P.B. (1994b). Bovine Cutaneous Papillomas Associated with Bovine Papillomavirus Type-5. Archives of Virology 138, 373-377.
9. Bogaert L., Van Poucke M., De Baere C., Dewulf J., Peelman L., Ducatelle R., Gasthuys F., Martens A. (2007). Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid. Journal of General Virology 88, 2155-2161.
10. Borzacchiello G., Iovane G., Marcante M.L., Poggiali F., Roperto F., Roperto S., Venuti A. (2003). Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows. Journal of General Virology 84, 2921-2926.
11. Brostrom H., Bredbergraden U., England J., Obel N., Perlmann P. (1979). Cell-Mediated-Immunity in Horses with Sarcoid Tumors Against Sarcoid Cells Invitro. American Journal of Veterinary Research 40, 1701-1706.
12. Bucher K., Szalai G., Marti E., GriotWenk M.E., Lazary S. (1996). Tumour suppressor gene p53 in the horse: Identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid. Research in Veterinary Science 61, 114-119.
13. Campo M.S. (1988). Viral and Cellular Oncogenes in Papillomavirus- Associated Cancers. British Journal of Cancer 58, 80-84.
14. Campo M.S. (1997). Bovine papillomavirus and cancer. Veterinary Journal 154, 175-188.
15. Campo M.S. (1987). Papillomas and Cancer in Cattle. Cancer Surveys 6, 39-54.
16. Campo M.S. (1992). Cell-Transformation by Animal Papillomaviruses. Journal of General Virology 73, 217-222.
17. Campo M.S., Jarrett W.F.H. (1986). Papillomavirus Infection in Cattle - Viral and Chemical Cofactors in Naturally-Occurring and Experimentally Induced-Tumors. Ciba Foundation Symposia 120, 117-135.
18. Carr E.A., Theon A.P., Madewell B.R., Griffey S.M., Hitchcock M.E. (2001a). Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. American Journal of Veterinary Research 62, 741-744.
19. Carr E.A., Theon A.P., Madewell B.R., Hitchcock M.E., Schlegel R., Schiller J.T. (2001b). Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. American Journal of Veterinary Research 62, 1212-1217.
20. Chambers G., Ellsmore V.A., O'Brien P.M., Reid S.W.J., Love S., Campo M.S., Nasir L. (2003a). Association of bovine papillomavirus with the equine sarcoid. Journal of General Virology 84, 1055-1062.
21. Chambers G., Ellsmore V.A., O'Brien P.M., Reid S.W.J., Love S., Campo M.S., Nasir L. (2003b). Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Research 96, 141-145.
22. Chan S.Y., Ho L., Ong C.K., Chow V., Drescher B., Durst M., Termeulen J., Villa L., Luande J., Mgaya H.N., Bernard H.U. (1992). Molecular Variants of Human Papillomavirus Type-16 from 4 Continents Suggest Ancient Pandemic Spread of the Virus and Its Coevolution with Humankind. Journal of Virology 66, 2057-2066.
23. Cheevers W.P., Roberson S.M., Brassfield A.L., Davis W.C., Crawford T.B. (1982). Isolation of A Retrovirus from Cultured Equine Sarcoid Tumor-Cells. American Journal of Veterinary Research 43, 804-806.
24. Chen E.Y., Howley P.M., Levinson A.D., Seeburg P.H. (1982). The Primary Structure and Genetic Organization of the Bovine Papillomavirus Type-1 Genome. Nature 299, 529-534.
25. Chen J.J., Reid C.E., Band V., Androphy E.J. (1995). Interaction of Papillomavirus E6 Oncoproteins with A Putative Calcium-Binding Protein. Science 269, 529-531.
26. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. (2004). Classification of papillomaviruses. Virology 324, 17-21.
27. DiMaio D., Mattoon D. (2001). Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20, 7866-7873.
28. England J.J., Watson R.E., Larson K.A. (1973). Virus-Like Particles in An Equine Sarcoid Cell Line. American Journal of Veterinary Research 34, 1601-1603.
29. Giannoudis A., Herrington C.S. (2001). Human papillomavirus variants and squamous neoplasia of the cervix. Journal of Pathology 193, 295-302.
30. Goodrich L., Gerber H., Marti E., Antczak D.F. (1998). Equine sarcoids. Veterinary Clinics of North America: Equine Practice 14, 607-623.
31. Gorman N.T. (1985). Equine Sarcoid - Time for Optimism. Equine Veterinary Journal 17, 412-414.
32. Jackson C. (1936). The incidence and pathology of tumours of domesticated animals in South Africa. The Onderstepoort Journal of Veterinary Science and Animal Industry 6, 375-385.
33. Jarrett W.F.H. (1984). Papillomaviruses. British Journal of Cancer 50, 241-241.
34. Koller L.D., Olson C. (1972). Attempted transmission of warts from man, cattle, and horses and of deer fibroma, to selected hosts. Journal of Investigative Dermatology 58, 366-368.
35. Lancaster W.D., Olson C., Meinke W. (1977). Bovine Papilloma-Virus - Presence of Virus-Specific Dna Sequences in Naturally Occurring Equine Tumors. In: Proceedings of the National Academy of Sciences of the United States of America 74, 524-528.
36. Levinc A.J., Chang A.W., Dittmer D., Notterman D.A., Silver A., Thorn K., Welsh D., Wu M. (1994). The P53 Tumor-Suppressor Gene. Journal of Laboratory and Clinical Medicine 123, 817-823.
37. Makady F.M., Mahmoud A.Z., Seleim M.A., Karram M.H. (1990). Relationship between bovine papilloma and equine sarcoid: experimental inoculation of donkeys with bovine papilloma extract. Assiut Veterinary Medical Journal 24, 124-133.
38. Marchetti B., Ashrafi G.H., Tsirimonaki E., O'Brien P.M., Campo M.S. (2002). The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene 21, 7808-7816.
39. Martens A., De Moor A., Demeulemeester J., Ducatelle R. (2000). Histopathological characteristics of five clinical types of equine sarcoid. Research in Veterinary Science 69, 295-300.
40. Martens A., De Moor A., Demeulemeester J., Peelman L. (2001). Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA. Veterinary Surgery 30, 460-467.
41. McBride A.A., Romanczuk H., Howley P.M. (1991). The Papillomavirus-E2 Regulatory Proteins. Journal of Biological Chemistry 266, 18411-18414.
42. Morgan I.M., Campo M.S. (2000). Recent developments in bovine papillomaviruses. Papillomavirus Report 11, 127-132.
43. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. (2006). HPV in the etiology of human cancer. Vaccine 24, 1-10.
44. Nasir L., Gault E., Morgan I.M., Chambers G., Ellsmore V., Campo M.S. (2007). Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology 364, 355-361.
45. Nasir L., McFarlane S.T., Reid S.W.J. (1999). Mutational status of the tumour suppressor gene (p53) in donkey sarcoid tumours. Veterinary Journal 157, 99-101.
46. Nasir L., McFarlane S.T., Torrontegui B.O., Reid S.W.J. (1997). Screening for bovine papillomavirus in peripheral blood cells of donkeys with and without sarcoids. Research in Veterinary Science 63, 289-290.
47. Nasir L., Reid S.W.J. (1999). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Research 61, 171-175.
48. Ned R., Allen S., Pol S.V. (1997). Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6. Journal of Virology 71, 4866-4870.
49. Nel P.J., Bertschinger H., Williams J., Thompson P.N. (2006). Descriptive study of an outbreak of equine sarcoid in a population of Cape mountain zebra (Equus zebra zebra) in the Gariep Nature Reserve. Journal of the South African Veterinary Association-Tydskrif Van Die Suid-Afrikaanse Veterinere Vereniging 77, 184-190.
50. Nicholls P.K., Stanley M.A. (2000). The immunology of animal papillomaviruses. Veterinary Immunology and Immunopathology 73, 101-127.
51. Nixon C., Chambers G., Ellsmore V., Campo M.S., Burr P., Argyle D.J., Reid S.W.J., Nasir L. (2005). Expression of cell cycle associated proteins cyclin A, CDK-2, p27(kip1) and p53 in equine sarcoids. Cancer Letters 221, 237-245.
52. Obanion M.K., Reichmann M.E., Sundberg J.P. (1986). Cloning and Characterization of An Equine Cutaneous Papillomavirus. Virology 152, 100-109.
53. Ogawa T., Tomita Y., Okada M., Shirasawa H. (2007). Complete genome and phylogenetic position of bovine papillomavirus type 7. Journal of General Virology 88, 1934-1938.
54. Olson C., Cook R.H. (1951). Cutaneous sarcoma-like lesions of the horse caused by the agent of bovine papilloma. Proceedings of the Society for Experimental Biology and Medicine 77, 281-284.
55. Otten N., von Tscharner C., Lazary S., Antczak D.F., Gerber H. (1993). DNA of bovine papillomavirus type-1 and type-2 in equine sarcoids - PCR detection and direct sequencing. Archives of Virology 132, 121-131.
56. Petti L., DiMaio D. (1992). Stable Association Between the Bovine Papillomavirus-E5 Transforming Protein and Activated Platelet-Derived Growth-Factor Receptor in Transformed Mouse Cells. In: Proceedings of the National Academy of Sciences of the United States of America 89, 6736-6740.
57. Phelps W.C., Bream G.L., McBride A.A. (1999). Papillomaviruses - Animal. In: Granoff A. and Webster R.G. (editors). Encyclopedia of Virology. Academic Press Limited, London, p. 1121-1130.
58. Ragland W.L. (1970). Equine sarcoid. Equine Veterinary Journal 2, 2-11.
59. Ragland W.L., Keown G.H., Gorham J.R. (1966). An epizootic of equine sarcoid. Nature 210, 1399-
60. Ragland W.L., McLaughin C.A., Spencer G.R. (1970). Attempts to relate bovine papilloma virus to the cause of equine sarcoid: horses, donkeys and calves inoculated with equine sarcoid extracts. Equine Veterinary Journal 2, 168-172.
61. Ragland W.L., Spencer G.R. (1969). Attempts to relate bovine papilloma virus to the cause of equine sarcoids: equidae inoculated intradermally with bovine papilloma virus. American Journal of Veterinary Research 30, 743-752.
62. Ragland W.L., Spencer G.R. (1968). Attempts to relate bovine papilloma virus to the cause of equine sarcoid: immunity to bovine papilloma virus. American Journal of Veterinary Research 29, 1363-1366.
63. Rapp L., Liu Y., Hong Y.H., Androphy E.J., Chen J.J. (1999). The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis. Oncogene 18, 607-615.
64. Reid S.W.J., Gettinby G., Fowler J.N., Ikin P. (1994a). Epidemiologic observations on sarcoids in a population of donkeys (Equus-Asinus). The Veterinary Record 134, 207-211.
65. Reid S.W.J., Smith K.T., Jarrett W.F.H. (1994b). Detection, cloning and characterization of papillomaviral DNA present in sarcoid tumors of Equus-Asinus. The Veterinary Record 135, 430-432.
66. Roberts S. (2006). The E4 protein - a late starter. In: Campo M.S. (editor). Papillomavirus Research: From Natural History to Vaccines and Behond. Caister Academic Press, Wymondham, p. 81-96.
67. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. (1990). The E6 Oncoprotein Encoded by Human Papillomavirus Type-16 and Type-18 Promotes the Degradation of P53. Cell 63, 1129-1136.
68. Sousa R., Dostatni N., Yaniv M. (1990). Control of papillomavirus gene expression. Biochimica et Biophysica Acta 1032, 19-37.
69. Stanley M., Lowy D.R., Frazer I. (2006). Prophylactic HPV vaccines: Underlying mechanisms. Vaccine 24, 106-113.
70. Sundberg J.P., Junge R.E., Lancaster W.D. (1984). Immunoperoxidase Localization of Papillomaviruses in Hyperplastic and Neoplastic Epithelial Lesions of Animals. American Journal of Veterinary Research 45, 1441-1446.
71. Teifke J.P., Hardt M., Weiss E. (1994). Detection of bovine papillomavirus DNA in formalin-fixed and paraffin-embedded equine sarcoids by polymerase chain reaction and non-radioactive in situ hybridization. European Journal of Veterinary Pathology 1, 5-10.
72. Tomita Y., Literak I., Ogawa T., Jin Z., Shirasawa H. (2007). Complete genomes and phylogenetic positions of bovine papillomavirus type 8 and a variant type from a European bison. Virus Genes 35, 243-249.
73. Tong X., Boll W., Kirchhausen T., Howley P.M. (1998). Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. Journal of Virology 72, 476-482.
74. Tong X., Salgia R., Li J.L., Griffin J.D., Howley P.M. (1997). The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. Journal of Biological Chemistry 272, 33373-33376.
75. Tong X.A., Howley P.M. (1997). The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. In: Proceedings of the National Academy of Sciences of the United States of America 94, 4412-4417.
76. Trenfield K., Spradbrow P.B., Vanselow B. (1985). Sequences of papillomavirus DNA in equine sarcoids. Equine Veterinary Journal 17, 449-452.
77. Vande Pol S.B., Brown M.C., Turner C.E. (1998). Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16, 43-52.
78. Voss J.L. (1969). Transmission of equine sarcoid. American Journal of Veterinary Research 30, 183-191.
79. Yuan Z., Gallagher A., Gault E.A., Campo M.S., Nasir L. (2006). Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Veterinary Journal 174, 599-604.
80. Zimmermann H., Koh C.H., Degenkolbe R., O'Connor M.J., Muller A., Steger G., Chen J.J., Lui Y., Androphy E., Bernard H.U. (2000). Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. Journal of General Virology 81, 2617-2623.